Sequentially Responsive Three-Lobed Supramolecular Platform for Tumor Microenvironment Remodeling and Blood-Brain Barrier Penetration. [PDF]
Huang M +6 more
europepmc +1 more source
Association of Pregabalin vs. Duloxetine with Cardiovascular Events: A Retrospective Cohort Study Among US Veterans With Chronic Musculoskeletal Pain. [PDF]
Campbell S +11 more
europepmc +1 more source
Antisuicidal Effect of Lamotrigine Augmentation in Treatment-Resistant Depression: A Case Report. [PDF]
Hsiung K, Amison T.
europepmc +1 more source
Metabolomic Profiling of Extracellular Vesicles Reveals Distinct Metabolic Dysregulation and Treatment-Specific Signatures in Depression. [PDF]
Balic N +17 more
europepmc +1 more source
Effects of celecoxib combined with duloxetine on chronic pain, depression, and anxiety in patients with knee osteoarthritis. [PDF]
Liu X +5 more
europepmc +1 more source
Efficacy of duloxetine in treating temporomandibular joint disorder: a systematic review with bayesian meta-analysis. [PDF]
Sivakumar S +4 more
europepmc +1 more source
Related searches:
The fixed-dose combination of pregabalin and duloxetine hydrochloride is mainly used in the treatment of neuropathic pain. Sensitive determination of drugs like pregabalin is challenging by chromatographic methods using UV detection due to their ...
Susheel John Varghese +1 more
exaly +2 more sources
Prurigo successfully treated with duloxetine hydrochloride
Australasian Journal of Dermatology, 2019Prurigo is a common skin disease characterised by erythematous macules and papules/nodules with severe pruritus. We report here two cases with treatment‐resistant prurigo that were successfully treated with duloxetine hydrochloride, a serotonin ...
T. Hashimoto, T. Satoh, H. Yokozeki
semanticscholar +3 more sources
Optimization and in vivo evaluation of duloxetine hydrochloride buccoadhesive lyophilized tablets
Journal of Drug Delivery Science and Technology, 2019Duloxetine hydrochloride (DH) is a serotonin-norepinephrine reuptake inhibitor (SSNRI) indicated for the treatment of depression. Duloxetine suffers from reduced oral bioavailability (≈50%) due to hepatic metabolism.
Ahmed Hassen Elshafeey
exaly +2 more sources

